Holly A. Fowle

发表

PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55α/PP2A reconstitution that triggers centrosome destabilization

James S. Duncan, C. Lindskog, A. Nikonova, 2019, Oncogenesis.

Models of habitat suitability, size, and age-class structure for the deep-sea black coral Leiopathes glaberrima in the Gulf of Mexico

D. Wagner, Erik Cordes, Peter J Etnoyer, 2017 .

Expanding the Prostate Cancer Cell Line Repertoire with ACRJ-PC28, an AR-negative Neuroendocrine Cell Line Derived From an African-Caribbean Patient

Yan Zhou, N. Lee, X. Graña, 2022, Cancer research communications.

PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer.

X. Graña, Holly Fowle, Ziran Zhao, 2019, Advances in cancer research.

PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107

Roland L. Dunbrack, Qifang Xu, X. Graña, 2021, bioRxiv.

Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase

J. Testa, X. Graña, Yinfei Tan, 2020, Prostate cancer and prostatic diseases.

FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55⍺/PP2A phosphatase

James S. Duncan, R. Dunbrack, Qifang Xu, 2023, bioRxiv.

PP 2 A / B 55 α substrate recruitment as defined by the retinoblastoma-related protein p 107

R. Dunbrack, Qifang Xu, X. Graña, 2022 .

FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55⍺/PP2A phosphatase

James S. Duncan, R. Dunbrack, Qifang Xu, 2023, bioRxiv.

Protocol to assess substrate dephosphorylation by serine/threonine phosphoprotein phosphatases in vitro

X. Graña, Felicity Feiser, Holly A. Fowle, 2023, STAR protocols.